UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002770 |
|---|---|
| Receipt number | R000003211 |
| Scientific Title | Photodynamic therapy with two third dose verteporfin for central serous chorioretinopathy:Prospective intervention trial |
| Date of disclosure of the study information | 2009/11/17 |
| Last modified on | 2016/05/17 11:51:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/11/17 02:20:49 | ||
| 2 | Update | 2009/11/17 02:22:26 | Recruitment status |
|
| 3 | Update | 2009/11/29 18:49:28 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2009/11/29 19:06:07 | Key inclusion criteria |
|
| 5 | Update | 2009/11/29 19:09:13 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2009/11/29 19:14:10 | Primary outcomes Key secondary outcomes |
|
| 7 | Update | 2009/11/29 21:26:46 | Interventions/Control_1 |
|
| 8 | Update | 2009/11/29 21:27:59 | TEL TEL Institutions |
|
| 9 | Update | 2010/01/03 12:47:55 | Key secondary outcomes Key secondary outcomes |
|
| 10 | Update | 2011/12/25 23:52:38 | Last name of lead principal investigator Last name of lead principal investigator Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 11 | Update | 2012/02/09 19:20:20 | Last follow-up date |
|
| 12 | Update | 2014/05/17 16:58:19 | Email Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 13 | Update | 2014/11/18 01:20:59 | Recruitment status |
|
| 14 | Update | 2016/05/17 11:48:37 | Recruitment status |
|
| 15 | Update | 2016/05/17 11:51:13 | Name of primary person or sponsor Organization |
